These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22903525)

  • 1. A survey of applications of biological products for drug interference of immunogenicity assays.
    Wang YM; Fang L; Zhou L; Wang J; Ahn HY
    Pharm Res; 2012 Dec; 29(12):3384-92. PubMed ID: 22903525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An innovative method for characterizing neutralizing antibodies against antibody-derived therapeutics.
    Coddens A; Snoeck V; Bontinck L; Buyse MA; Pine SO
    J Immunol Methods; 2020 Dec; 487():112896. PubMed ID: 33065122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating and Reporting the Immunogenicity Impacts for Biological Products--a Clinical Pharmacology Perspective.
    Wang YM; Wang J; Hon YY; Zhou L; Fang L; Ahn HY
    AAPS J; 2016 Mar; 18(2):395-403. PubMed ID: 26721560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays.
    Zoghbi J; Xu Y; Grabert R; Theobald V; Richards S
    J Immunol Methods; 2015 Nov; 426():62-9. PubMed ID: 26255760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Utility of an ELISA Method for Sensitive and Specific Detection of IgE Antidrug Antibodies.
    Zhong ZD; Jiang LL; Khandelwal P; Clarke AW; Bakhtiar R; Zou L
    AAPS J; 2020 Jan; 22(2):36. PubMed ID: 31997031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immunogenicity of Biologic Therapies.
    Garcês S; Demengeot J
    Curr Probl Dermatol; 2018; 53():37-48. PubMed ID: 29131036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quartz crystal microbalance as an assay to detect anti-drug antibodies for the immunogenicity assessment of therapeutic biologics.
    Dubiel EA; Fülöp T; Vigier S; Vermette P
    Anal Bioanal Chem; 2017 Dec; 409(30):7153-7167. PubMed ID: 29026983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Supersensitive Anti-Drug Antibody Assay: Unexpected High Anti-Drug Antibody Incidence and Its Clinical Relevance.
    Song S; Yang L; Trepicchio WL; Wyant T
    J Immunol Res; 2016; 2016():3072586. PubMed ID: 27340678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic characterization of anti-drug antibody responses for the assessment of clinical relevance and impact.
    Tatarewicz SM; Mytych DT; Manning MS; Swanson SJ; Moxness MS; Chirmule N
    Bioanalysis; 2014 Jun; 6(11):1509-23. PubMed ID: 25046051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of therapeutic protein products: current considerations for anti-drug antibody assay in Japan.
    Ishii-Watabe A; Shibata H; Nishimura K; Hosogi J; Aoyama M; Nishimiya K; Saito Y
    Bioanalysis; 2018 Jan; 10(2):95-105. PubMed ID: 29243491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of Therapeutic Antibodies: Monitoring Antidrug Antibodies in a Clinical Context.
    Bloem K; Hernández-Breijo B; Martínez-Feito A; Rispens T
    Ther Drug Monit; 2017 Aug; 39(4):327-332. PubMed ID: 28463887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of biologic therapies in psoriasis: Myths, facts and a suggested approach.
    Tsakok T; Rispens T; Spuls P; Nast A; Smith C; Reich K
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):329-337. PubMed ID: 33030275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for identification of outliers in immunogenicity assay cut point data.
    Zhang J; Arends RH; Kubiak RJ; Roskos LK; Liang M; Lee N; Chen CC; Yang H
    J Immunol Methods; 2020; 484-485():112817. PubMed ID: 32615125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients.
    Bloem K; van Leeuwen A; Verbeek G; Nurmohamed MT; Wolbink GJ; van der Kleij D; Rispens T
    J Immunol Methods; 2015 Mar; 418():29-38. PubMed ID: 25637408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on the AAPS Immunogenicity Guidance Forum.
    Myler H; Gorovits B; Phillips K; Devanarayan V; Clements-Egan A; Gunn GR; Kirshner S; DeSilva B; Shah VP
    AAPS J; 2019 Apr; 21(4):55. PubMed ID: 30993501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigating target interference in bridging immunogenicity assay with target-blocking reagents and mild basic pH.
    Chen J; Garlits J; Dhulipala G; Sirimanne T; Xu C; Lu K; Palackal N; Pyles E; Torri A; Sumner G
    Bioanalysis; 2019 Sep; 11(17):1569-1580. PubMed ID: 31208197
    [No Abstract]   [Full Text] [Related]  

  • 17. Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles.
    Goodman J; Cowen S; Devanarayan V; Egging D; Emrich T; Golob M; Kramer D; McNally J; Munday J; Nelson R; Pedras-Vasconcelos JA; Piironen T; Sickert D; Skibeli V; Fjording MS; Timmerman P
    Bioanalysis; 2018 Feb; 10(4):197-204. PubMed ID: 29345496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin-5 induced false positive anti-drug antibody responses against mepolizumab through the use of a competitive blocking antibody.
    Liao K; Meyer E; Lee TN; Loercher A; Sikkema D
    J Immunol Methods; 2017 Feb; 441():15-23. PubMed ID: 27889561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals.
    Gunn GR; Sealey DC; Jamali F; Meibohm B; Ghosh S; Shankar G
    Clin Exp Immunol; 2016 May; 184(2):137-46. PubMed ID: 26597698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-drug Antibody Assay Conditions Significantly Impact Assay Screen and Confirmatory Cut-Points.
    Gorovits B; Wang Y; Zhu L; Araya M; Kamerud J; Lepsy C
    AAPS J; 2019 Jun; 21(4):71. PubMed ID: 31161482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.